KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Incyte (INCY) Revenue (2016 - 2026)

Incyte filings provide 17 years of Revenue readings, the most recent being $1.3 billion for Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 20.87% year-over-year to $1.3 billion, compared with a TTM value of $5.4 billion through Mar 2026, up 21.48%, and an annual FY2025 reading of $5.1 billion, up 21.22% over the prior year.
  • Revenue hit $1.3 billion in Q1 2026 for Incyte, down from $1.5 billion in the prior quarter.
  • The five-year high for Revenue was $1.5 billion in Q4 2025, with the low at $733.2 million in Q1 2022.
  • Median Revenue over the past 5 years was $1.0 billion (2023), compared with a mean of $1.0 billion.
  • The largest YoY upside for Revenue was 29.15% in 2022 against a maximum downside of 1.27% in 2022.
  • Year by year, Revenue stood at $926.7 million in 2022, then grew by 9.35% to $1.0 billion in 2023, then rose by 16.32% to $1.2 billion in 2024, then grew by 27.84% to $1.5 billion in 2025, then decreased by 15.54% to $1.3 billion in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $1.3 billion, $1.5 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.